Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
    • Article CME
    • Podcast CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
    • Article CME
    • Podcast CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Neurology Clinical Practice
Home
A peer-reviewed clinical neurology journal for the practicing neurologist
  • Subscribe
  • My alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current

Share

July 11, 2019Research

Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants

Christopher G. Tarolli, Grace A. Zimmerman, Steven Goldenthal, Blake Feldman, Sarah Berk, Bernadette Siddiqi, Catherine M. Kopil, Sohini Chowdhury, Kevin M. Biglan, E. Ray Dorsey, Jamie L. Adams
First published July 11, 2019, DOI: https://doi.org/10.1212/CPJ.0000000000000680
Christopher G. Tarolli
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace A. Zimmerman
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Goldenthal
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blake Feldman
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Berk
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadette Siddiqi
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine M. Kopil
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sohini Chowdhury
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin M. Biglan
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Ray Dorsey
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamie L. Adams
Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants
Christopher G. Tarolli, Grace A. Zimmerman, Steven Goldenthal, Blake Feldman, Sarah Berk, Bernadette Siddiqi, Catherine M. Kopil, Sohini Chowdhury, Kevin M. Biglan, E. Ray Dorsey, Jamie L. Adams
Neurol Clin Pract Jul 2019, 10.1212/CPJ.0000000000000680; DOI: 10.1212/CPJ.0000000000000680

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
29

Share

  • Article
  • Info & Disclosures
Loading

Article Information

10.1212/CPJ.0000000000000680
DOI: 
https://doi.org/10.1212/CPJ.0000000000000680

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received February 12, 2019
  • Accepted April 23, 2019
  • First Published July 11, 2019.

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Christopher G. Tarolli, MD,
    2. Grace A. Zimmerman, BS,
    3. Steven Goldenthal, BA,
    4. Blake Feldman, BA,
    5. Sarah Berk, MPH,
    6. Bernadette Siddiqi, MA,
    7. Catherine M. Kopil, PhD,
    8. Sohini Chowdhury, MA,
    9. Kevin M. Biglan, MD, MPH,
    10. E. Ray Dorsey, MD and
    11. Jamie L. Adams, MD
  1. Christopher G. Tarolli, MD,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. (1) Genzyme - Fellow Scholarship to AAN Annual Meeting (2017) (2) American Academy of Neurology - covered travel cost, AAN Annual Meeting (2018, 2019), Breakthroughs in Neurology Conference (2018), and AAN Fall Conference (2018)

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other activities:
    1. (1) Medtronic - partial salary support for sponsored fellowship in Movement disorders (2017)

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Biosensics

    Research Support, Government Entities:
    1. (1) NIH/NINDS

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) American Academy of Neurology Institute (2) Michael J. Fox Foundation for Parkinson's Research (3) Greater Rochester Health Foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Grace A. Zimmerman, BS,
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Steven Goldenthal, BA,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  7. Blake Feldman, BA,
  8. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. Sarah Berk, MPH,
  10. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  11. Bernadette Siddiqi, MA,
  12. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. World BI Group (UK), flight and hotel accommodations ExL Events, flight and hotel accommodations

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  13. Catherine M. Kopil, PhD,
  14. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  15. Sohini Chowdhury, MA,
  16. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  17. Kevin M. Biglan, MD, MPH,
  18. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Editorial Board, Journal of Huntington disease, 2011- Executive Committee Member, Huntington Study Group 2016-

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. I am currently employed by Eli Lilly Stock/Stock Options, Medical Equipment & Materials: Eli Lilly, 2017, 2018, 2019

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  19. E. Ray Dorsey, MD and
  20. Scientific Advisory Boards:
    1. Medical Advisory Board, Grand Rounds, an online second opinion service

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. received travel funding and/or honoraria from the American Academy of Neurology, American Neurological Association, University of Michigan

    Editorial Boards:
    1. Editorial board member for the Journal of Huntington's Disease; Editor of HD Insights; Editor of Digital Biomarkers

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. 23andMe, Abbott, Abbvie, American Well Biogen, Clintrex, DeciBio, Denali Therapeutics, GlaxoSmithKline, Grand Rounds, Karger, Lundbeck, MC10, MedAvante, Medico Legal services, Mednick Associates, NIH/NINDS, Olson Research Group, Optio, Origent Data Sciences, Prilenia, Putnam Associates, Roche, Sanofi, Shire, Sunovion Pharma, Teva, UCB, Voyager Therapeutics,

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical procedures or imaging studies:
    1. Clinical practice, including telemedicine, as a movement disorder neurologist (20%)

    Research Support, Commercial Entities:
    1. Abbvie, AMC Health, Avid Radiopharmaceuticals, BioMarin, GlaxoSmithKline, Great Lakes Neurotechnologies, Lundbeck, Medtronic, Prana Biotechnology, Raptor Pharmaceuticals, Roche, Teva Pharmaceuticals

    Research Support, Government Entities:
    1. National Institute of Neurological Disorders and Stroke, Patient-Centered Outcomes Research Institute

    Research Support, Academic Entities:
    1. University of California Irvine, Duke University

    Research Support, Foundations and Societies:
    1. Burroughs Wellcome Fund, Davis Phinney Foundation, Michael J. Fox Foundation, Safra Foundation, Greater Rochester Health Foundation, Huntington Study Group, National Science Foundation Stock/Stock Options, Medical Equipment & Materials: Grand Rounds (stock options) BlackFynn (stock options)

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. has received compensation for expert testimony

  21. Jamie L. Adams, MD
  22. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. (1) Huntington Study Group, speaker honorarium

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. (1) VisualDx

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Biogen (2) Biosensics (3) Pfizer (4) Azevan Pharmaceuticals

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) The Michael J. Fox Foundation (2) Safra Foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
  1. Correspondence
    Dr. Tarolli christopher_tarolli{at}urmc.rochester.edu

Article usage

Article usage: July 2019 to November 2019

AbstractFullPdfSource
Jul 2019138012Highwire
Aug 20197806Highwire
Sep 20193904Highwire
Oct 20194502Highwire
Nov 20192805Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.cp.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on The Nerve!

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate The Nerve! Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Movement Disorders
  • Dementia with Lewy bodies
  • Progressive supranuclear palsy
  • Corticobasal degeneration
  • Multiple system atrophy

Alert Me

  • Alert me when this article is cited
  • Alert me if a correction is posted
  • Alert me when eletters are published
Neurology: Clinical Practice: 9 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Clinical Practice |  Print ISSN: 2163-0402
Online ISSN: 2163-0933

© 2019 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise